Synergistic Endometrial Ablation System

Publication ID: 24-11857248_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Endometrial Ablation System,” Published Technical Disclosure No. 24-11857248_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857248_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,248.

Summary of the Inventive Concept

The present inventive concept integrates radio frequency-based endometrial ablation technology with advanced technologies such as machine learning, blockchain, IoT, and nanomaterials to create a more efficient, personalized, and secure system for treating menorrhagia.

Background and Problem Solved

The original patent disclosed a radio frequency-based endometrial ablation system for treating menorrhagia. However, the system had limitations in terms of optimizing treatment parameters, securing patient data, and enhancing tissue detection. The present inventive concept addresses these limitations by incorporating synergistic combinations of distinct technologies to create a more advanced and effective system.

Detailed Description of the Inventive Concept

The synergistic endometrial ablation system comprises a radio frequency-based ablation device, a machine learning module for predicting optimal ablation parameters based on patient-specific data, a blockchain-based data management system for securing and sharing patient data and treatment outcomes, an IoT-enabled sensor array for real-time monitoring of treatment parameters, and nanomaterial-enhanced tissue sensing for enhanced tissue detection. The AI-driven simulation platform generates customized treatment plans based on patient-specific anatomy and physiology. The system enables real-time monitoring, personalized treatment planning, and secure data management, thereby improving treatment outcomes and patient satisfaction.

Novelty and Inventive Step

The novel and non-obvious aspects of the present inventive concept lie in the integration of advanced technologies with radio frequency-based endometrial ablation technology to create a more efficient, personalized, and secure system. The combination of machine learning, blockchain, IoT, and nanomaterials with radio frequency ablation technology is unprecedented and provides a significant improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic endometrial ablation system may include variations in the type of advanced technologies used, such as using different machine learning algorithms or incorporating other sensing modalities. Additionally, the system may be adapted for use in other medical applications, such as cancer treatment or cosmetic procedures.

Potential Commercial Applications and Market

The synergistic endometrial ablation system has significant commercial potential in the medical device industry, particularly in the women's health segment. The system's ability to provide personalized treatment plans, real-time monitoring, and secure data management makes it an attractive solution for healthcare providers and patients. The market for endometrial ablation devices is growing, and the present inventive concept is poised to capture a significant share of this market.

CPC Classifications

SectionClassGroup
A A61 A61B18/1485
A A61 A61B5/1076
A A61 A61B18/042
A A61 A61B2018/0022
A A61 A61B2018/00214
A A61 A61B2018/00559
A A61 A61B2018/00577
A A61 A61B2018/00666
A A61 A61B2018/147
A A61 A61B2090/064
A A61 A61B2218/008

Original Patent Information

Patent NumberUS 11,857,248
TitleMethods and systems for endometrial ablation utilizing radio frequency
Assignee(s)MINERVA SURGICAL, INC.